Bayer AG Stock

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate 11:33:34 2024-04-22 am EDT 5-day change 1st Jan Change
27.32 EUR +3.76% Intraday chart for Bayer AG +3.08% -18.90%
Sales 2024 * 47.22B 50.25B Sales 2025 * 48.14B 51.23B Capitalization 25.86B 27.52B
Net income 2024 * 2.23B 2.37B Net income 2025 * 3.16B 3.37B EV / Sales 2024 * 1.24 x
Net Debt 2024 * 32.69B 34.79B Net Debt 2025 * 29.48B 31.37B EV / Sales 2025 * 1.15 x
P/E ratio 2024 *
12 x
P/E ratio 2025 *
8.1 x
Employees 96,931
Yield 2024 *
0.42%
Yield 2025 *
0.92%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.56%
1 week+3.00%
Current month-4.13%
1 month+1.91%
3 months-17.04%
6 months-33.50%
Current year-18.96%
More quotes
1 week
25.61
Extreme 25.61
27.55
1 month
25.61
Extreme 25.61
28.94
Current year
24.96
Extreme 24.96
36.09
1 year
24.96
Extreme 24.96
60.81
3 years
24.96
Extreme 24.96
67.99
5 years
24.96
Extreme 24.96
78.34
10 years
24.96
Extreme 24.96
146.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 23-03-31
Director of Finance/CFO 54 18-04-25
Chief Tech/Sci/R&D Officer 55 20-03-31
Members of the board TitleAgeSince
Director/Board Member 68 17-03-31
Director/Board Member 68 17-03-31
Director/Board Member 67 21-03-31
More insiders
Date Price Change Volume
24-04-22 27.28 +3.63% 3 229 923
24-04-19 26.32 +0.32% 4,224,860
24-04-18 26.24 -0.04% 2,759,804
24-04-17 26.25 +0.65% 2,359,047
24-04-16 26.08 -1.44% 3,296,976

Delayed Quote Xetra, April 22, 2024 at 08:22 am EDT

More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.32 EUR
Average target price
37.05 EUR
Spread / Average Target
+40.73%
Consensus